Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2023

Nov 9, 2023

31971_dirs_2023-11-09_5794115a-1de6-442b-a9f6-00dad35c7aa4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-11-07

Reporting Person: Peters Stanley W III (President AS and AET)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-11-07 Common Stock M 1200 $41.93 Acquired 1263 Direct
2023-11-07 Common Stock S 1200 $102.395 Disposed 63 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-11-07 Options To Purchase Common Stock $41.93 M 1200 Disposed 2027-03-01 Common Stock (1200) Direct

Footnotes

F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.